These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15870287)

  • 1. Role of epidermal growth factor receptor signaling in RAS-driven melanoma.
    Bardeesy N; Kim M; Xu J; Kim RS; Shen Q; Bosenberg MW; Wong WH; Chin L
    Mol Cell Biol; 2005 May; 25(10):4176-88. PubMed ID: 15870287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras-induced melanoma transformation is associated with the proteasomal degradation of the transcriptional repressor ICER.
    Healey M; Crow MS; Molina CA
    Mol Carcinog; 2013 Sep; 52(9):692-704. PubMed ID: 22488648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression.
    Wang D; Yang W; Du J; Devalaraja MN; Liang P; Matsumoto K; Tsubakimoto K; Endo T; Richmond A
    Oncogene; 2000 Sep; 19(40):4647-59. PubMed ID: 11030154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin.
    Shields JM; Mehta H; Pruitt K; Der CJ
    Mol Cell Biol; 2002 Apr; 22(7):2304-17. PubMed ID: 11884615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation.
    Oberst MD; Beberman SJ; Zhao L; Yin JJ; Ward Y; Kelly K
    BMC Cancer; 2008 Jul; 8():189. PubMed ID: 18597688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that sprouty 2 is necessary for sarcoma formation by H-Ras oncogene-transformed human fibroblasts.
    Lito P; Mets BD; Kleff S; O'Reilly S; Maher VM; McCormick JJ
    J Biol Chem; 2008 Jan; 283(4):2002-9. PubMed ID: 18048363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
    Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
    Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways.
    Stecca B; Mas C; Clement V; Zbinden M; Correa R; Piguet V; Beermann F; Ruiz i Altaba A
    Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5895-900. PubMed ID: 17392427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.
    Janda E; Lehmann K; Killisch I; Jechlinger M; Herzig M; Downward J; Beug H; Grünert S
    J Cell Biol; 2002 Jan; 156(2):299-313. PubMed ID: 11790801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
    Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
    Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
    Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
    Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.
    Hoek K; Rimm DL; Williams KR; Zhao H; Ariyan S; Lin A; Kluger HM; Berger AJ; Cheng E; Trombetta ES; Wu T; Niinobe M; Yoshikawa K; Hannigan GE; Halaban R
    Cancer Res; 2004 Aug; 64(15):5270-82. PubMed ID: 15289333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
    Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis.
    Nogueira C; Kim KH; Sung H; Paraiso KH; Dannenberg JH; Bosenberg M; Chin L; Kim M
    Oncogene; 2010 Nov; 29(47):6222-32. PubMed ID: 20711233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression.
    Liu Y; Sánchez-Tilló E; Lu X; Huang L; Clem B; Telang S; Jenson AB; Cuatrecasas M; Chesney J; Postigo A; Dean DC
    J Biol Chem; 2014 Feb; 289(7):4116-25. PubMed ID: 24371144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells.
    Lin S; Yang J; Elkahloun AG; Bandyopadhyay A; Wang L; Cornell JE; Yeh IT; Agyin J; Tomlinson G; Sun LZ
    Mol Biol Cell; 2012 Apr; 23(8):1569-81. PubMed ID: 22357622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth.
    Riverso M; Montagnani V; Stecca B
    Oncogene; 2017 Jun; 36(23):3322-3333. PubMed ID: 28068326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAS transformation causes sustained activation of epidermal growth factor receptor and elevation of mitogen-activated protein kinase in human mammary epithelial cells.
    Martínez-Lacaci I; Kannan S; De Santis M; Bianco C; Kim N; Wallace-Jones B; Ebert AD; Wechselberger C; Salomon DS
    Int J Cancer; 2000 Oct; 88(1):44-52. PubMed ID: 10962438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated mutant NRas(Q61K) drives aberrant melanocyte signaling, survival, and invasiveness via a Rac1-dependent mechanism.
    Li A; Ma Y; Jin M; Mason S; Mort RL; Blyth K; Larue L; Sansom OJ; Machesky LM
    J Invest Dermatol; 2012 Nov; 132(11):2610-21. PubMed ID: 22718121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
    Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
    Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.